Longeveron initiated with a Buy at Roth MKM
Roth MKM last night initiated coverage of Longeveron (LGVN) with a Buy rating and $10 price target The firm says its investment thesis is driven by the 100% transplant-free survival benefits at the end of five years delivered by Lomecel-B in hypoplastic left heart syndrome.
We recently compiled a list of the 11 AI News You Should Not Miss. In this article, we are going to take a look at where ...
Yext (NYSE:YEXT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday,Benzinga reports. They presently have a $10.50 target ...
Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 from $45 and keeps a Buy rating on the shares. The company has reported ...
Roth MKM last night initiated coverage of Entrada Therapeutics (TRDA) with a Buy rating and $29 price target Entrada is an ...
Analysts at Roth Capital issued their Q1 2026 EPS estimates for shares of Uranium Energy in a research report issued to clients and investors on Monday, December 9th. Roth Capital analyst J. Reagor ...
Shares of Inseego (NASDAQ:INSG) moved higher in premarket trading on Thursday as Roth MKM raised its rating on the SaaS solutions provider to Buy and raised its price target on the stock to $15 ...
As of December 3, 2024, the average one-year price target for Longeveron is $8.67/share. The forecasts range from a low of $6.06 to a high of $10.50. The average price target represents an ...
ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors. Our full-service platform provides capital raising, high impact equity research ...
Roth MKM analyst Philip Shen maintained a Buy rating on Sunnova Energy International (NOVA – Research Report) today and set a price target of ...
Fintel reports that on December 5, 2024, Roth MKM initiated coverage of Gain Therapeutics (NasdaqGM:GANX) with a Buy recommendation. As of December 3, 2024, the average one-year price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback